A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate.
作者信息
Galeazzi M, Bazzichi L, Sebastiani G D, Neri D, Garcia E, Ravenni N, Giovannoni L, Wilton J, Bardelli M, Baldi C, Selvi E, Iuliano A, Minisola G, Caporali R, Prisco E, Bombardieri S
出版信息
Isr Med Assoc J. 2014 Oct;16(10):666.
PMID:25438467
Abstract
摘要
Zotero 插件